Semaglutide, also known as Ozempic, Wegovy and Rybelsus, and Tirzepatide, also known as Mounjara and Zepbound, are antidiabetic medications commonly used for the treatment of type 2 diabetes.

However, the FDA has approved both medications for weight management! It is indicated for patients with BMI of 27 with one chronic medical condition or > 30.

Yes!

The medication increases the amount of insulin produced by the pancreas and decreases the amount of glucagon produced by the liver. This combination results in reduced hunger and increased energy levels resulting in weight loss.

Live Well by Thrivin’ Health can help educate you about alternatives to injections while developing your weight management plan.

1. Once you are medically approved and your plan is developed, we will order your medication from the compounding pharmacy and have it sent to our office.

2. Upon your medications arrival we will reach out to you to set up your in-office education and ensure you are comfortable with administering the medication.

Patients with BMI of 27 with one chronic medical condition or BMI > 30.

Oral dosing varies based on medications. Injectables are given weekly at home.

Personal or family history of:

• Medullary Thyroid Carcinoma

• Multiple Endocrine Neoplasia Syndrome Type 2

• Constipation

• Abdominal pain

• Diarrhea

• Vomiting

• Nausea

Less common:

• Allergic reactions

• Kidney problems

• Low blood sugar

• People with heart problems can damage the retina of the eye